1,2,3,4-tetrahydro-1-(phenylmethyl)isoquinoline has been researched along with 3,4-dihydroxyphenylacetic acid in 2 studies
*3,4-Dihydroxyphenylacetic Acid: A deaminated metabolite of LEVODOPA. [MeSH]
*3,4-Dihydroxyphenylacetic Acid: A deaminated metabolite of LEVODOPA. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, K; Miyatake, T; Ren, J; Sano, T; Shinohara, T; Taguchi, K; Utsunomiya, I; Wasai, T | 1 |
| Antkiewicz-Michaluk, L; Lorenc-Koci, E; Michaluk, J; Mokrosz, M; Ohta, S; Romanska, I; Vetulani, J | 1 |
2 other study(ies) available for 1,2,3,4-tetrahydro-1-(phenylmethyl)isoquinoline and 3,4-dihydroxyphenylacetic acid
| Article | Year |
|---|---|
Biochemical and pathological study of endogenous 1-benzyl-1,2,3,4-tetrahydroisoquinoline-induced parkinsonism in the mouse.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Dopamine; Drug Administration Schedule; Homovanillic Acid; Hydroxyindoleacetic Acid; Isoquinolines; Male; Mice; Mice, Inbred C57BL; Nerve Tissue Proteins; Parkinson Disease; Parkinson Disease, Secondary; Serotonin; Substantia Nigra; Tetrahydroisoquinolines; Tyrosine 3-Monooxygenase | 2001 |
Different action on dopamine catabolic pathways of two endogenous 1,2,3,4-tetrahydroisoquinolines with similar antidopaminergic properties.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine; Dopamine Antagonists; Homovanillic Acid; Isoquinolines; Male; Motor Activity; Muscle Rigidity; Nucleus Accumbens; Rats; Rats, Wistar; Substantia Nigra; Tetrahydroisoquinolines | 2001 |